Recent developments and future perspectives of personalized oncology

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Advances in understanding molecular carcinogenesis are shifting oncology paradigms.
• Key mutations and molecular pathways driving tumor development are being identified.
• This molecular understanding creates opportunities for novel diagnostic and therapeutic strategies.

Purpose of the Study:

• To highlight the growing importance of molecular analysis in oncology.
• To discuss the role of molecular diagnostics in guiding individualized cancer therapy.
• To showcase examples of successful molecularly targeted therapies.

Main Methods:

• Characterization of key mutations and molecular pathways in tumor development.
• Identification of potential molecular targets for diagnosis and therapy.
• Review of established molecularly targeted therapies in clinical practice.

Main Results:

• Molecular diagnostics are becoming central to clinical care for predicting treatment response.
• Patient groups can be stratified based on molecular profiles for tailored interventions.
• Established targeted therapies include tyrosine kinase inhibitors, EGFR inhibitors, HER2/neu blockade, and ALK inhibitors.

Conclusions:

• Molecular profiling of individual tumors will be a cornerstone of future cancer care.
• Personalized therapy based on specific molecular profiles will become standard practice.
• Targeted substances will be preferentially used when available, guided by molecular data.